# Veracyte (VCYT) — Analyst Forecast

VCYT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vcyt/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 10 | 1 | 1 | 12 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $44.00 | $57.57 | $69.00 | 7 |

Last price $44.39 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 15, 2026 | Freedom Capital Markets | Maintained | Buy | $66.00 |
| Sep 9, 2026 | UBS | Maintained | Buy | $65.00 |
| Aug 4, 2026 | Morgan Stanley | Maintained | Underweight | $44.00 |
| Aug 4, 2026 | Stephens & Co. | Maintained | Overweight | $55.00 |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | $54.00 |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Hold | $50.00 |
| Jul 31, 2026 | Needham | Maintained | Buy | $69.00 |
| Jul 30, 2026 | Needham | Maintained | Buy | $69.00 |
| Jul 15, 2026 | Piper Sandler | Initiated Coverage | Overweight | $66.00 |
| Jul 14, 2026 | Canaccord Genuity | Maintained | Hold | $60.00 |
| Jul 9, 2026 | Morgan Stanley | Maintained | Underweight | $47.00 |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | $65.00 |
| Jun 1, 2026 | Needham | Maintained | Buy | $57.00 |
| May 28, 2026 | Needham | Maintained | Buy | $48.00 |
| May 6, 2026 | UBS | Maintained | Buy | $52.00 |
| May 6, 2026 | Canaccord Genuity | Maintained | Hold | $42.00 |
| Apr 20, 2026 | Canaccord Genuity | Maintained | Hold | $40.00 |
| Apr 13, 2026 | Jefferies | Initiated Coverage | Buy | $45.00 |
| Apr 1, 2026 | Needham | Maintained | Buy | $48.00 |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | $45.00 |

## Frequently Asked Questions

### What is the price target for VCYT stock?

The average 12-month analyst price target for Veracyte (VCYT) is $57.57, with a high estimate of $69.00 and a low of $44.00, across 7 analysts.

### Is VCYT a buy, sell, or hold?

Analysts covering Veracyte currently average a Buy rating: 10 buy, 1 hold and 1 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for VCYT?

The average price target of $57.57 implies 29.69% upside from the last price of $44.39.

### What is the latest analyst rating on VCYT?

On Sep 15, 2026, Freedom Capital Markets maintained Veracyte at Buy with a price target of $66.00.

## Similar Stocks

- [WST](https://www.lighthorse.io/tickers/wst) — West Pharmaceutical Services, Inc. Common Stock
- [GMED](https://www.lighthorse.io/tickers/gmed) — Globus Medical, Inc. Class A Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).